🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be conducted to evaluate the efficacy, safety, and tolerabi...
Status
Terminated
Location
Clinical Research Site
Start Date
2019-02-15
Trial ID
NCT03896945
To compare pharmacokinetics (PK) of AVP-786 (deuterated \[d6\] dextromethor...
Status
Completed
Location
Covance Dallas Clinical Research Unit
Start Date
2014-05-01
Trial ID
NCT02336347
The purpose of this study is to determine the effects of a potent CYP3A4 in...
Status
Completed
Location
Vince and Associates Clinical Research, Inc.
Start Date
2015-03-01
Trial ID
NCT02402595
Treatments Being Tested
This study will be conducted to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
MD First Research #767
Start Date
2017-10-13
Trial ID
NCT03393520
To assess the multiple-dose pharmacokinetics (PK), safety and tolerability ...
Status
Completed
Location
CMAX
Start Date
2013-09-01
Trial ID
NCT02174835
Participants with agitation secondary to dementia of the Alzheimer's type. ...
Status
Completed
Location
Clinical Research Site
Start Date
2015-07-23
Trial ID
NCT02442765
Treatment of disinhibition syndrome in participants with Neurodegenerative ...
Status
Terminated
Location
Cleveland Clinic Lou Ruvo Center for Brain Health
Start Date
2015-12-01
Trial ID
NCT02534038
The objectives of this 10-week study are to evaluate the efficacy, safety, ...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-01
Trial ID
NCT02153502
Treatments Being Tested
This study was conducted to evaluate the efficacy, safety, and tolerability...
Status
Terminated
Location
Clinical Research Site #840-020
Start Date
2020-09-11
Trial ID
NCT04464564
This study was conducted to evaluate the efficacy, safety, and tolerability...
Status
Terminated
Location
Clinical Research Site #840-081
Start Date
2020-07-13
Trial ID
NCT04408755